Staccato alprazolam is named as a drug or biological intervention in 2 clinical trials in our UK, USA and China trial registers, 1 of which is recruiting. The lead sponsor is UCB Biopharma SRL. Registered phase: Phase 3. Conditions studied include Stereotypical Prolonged Seizures.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT05077904 | A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures (ClinicalTrials.gov ↗) Stereotypical Prolonged Seizures |
Phase 3 | Recruiting |
| NCT05076617 | A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures (ClinicalTrials.gov ↗) Stereotypical Prolonged Seizures |
Phase 3 | By invitation |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Stereotypical Prolonged Seizures | 2 |
| Lead sponsor | Trials |
|---|---|
| UCB Biopharma SRL | 2 |
| Register | Staccato alprazolam trials |
|---|---|
| Clinical trials in UK | 2 |
| Clinical trials in USA | 2 |
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Staccato alprazolam works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Staccato alprazolam (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.